Worth Venture Partners’s Bionano Genomics BNGO Stock Holding History

Worth Venture Partners’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-134	Closed	-$58K	–	93
2019 Q3	$58K	Sell	134 -12	-8%	-$13.1K	0.03%	84
2019 Q2	$215K	Hold	146	–	–	0.12%	66
2019 Q1	$382K	Buy	146 +13	+10%	+$34.1K	0.21%	54
2018 Q4	$417K	Buy	133 +125	+1,563%	+$498K	0.32%	46
2018 Q3	$34K	Buy	+8	New	+$34.1K	0.03%	144

Other funds holding BNGO

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Worth Venture Partners's BNGO Position: Q4 2019 in Review

Worth Venture Partners sold out of Bionano Genomics (BNGO) in Q4 2019, closing a stake of 134 shares — an estimated $58K sold.

Worth Venture Partners first reported a position in BNGO in Q3 2018 and held it in 5 quarters. The position peaked at $417K in Q4 2018. 9 funds tracked by Wall St. Rank hold BNGO as of Q4 2019.

Worth Venture Partners reported no remaining Bionano Genomics position as of Q4 2019 after selling out during the quarter.
Worth Venture Partners sold 134 Bionano Genomics shares in Q4 2019, an estimated $58K.
Worth Venture Partners first reported a position in Bionano Genomics in Q3 2018 and held it in 5 quarters.
Worth Venture Partners's Bionano Genomics position peaked at $417K in Q4 2018.
9 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2019.

Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.